Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primaquine Efficacy in Asymptomatic Malaria Carriers
NCT01838902Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Aug 2013
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of primaquine in malaria (4 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Prevalence of P. falciparum gametocyte carriers (QT-NASBA) at Day 7. Started Aug 2013; status: completed.
02
Drugs
primaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT01838902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01838902.